Global Enoxolone Market Size By Type (Injection, Tablet), By Application (Peptic Ulcer Teatment, Antitussive), By Region, And Segment Forecasts, 2023 to 2032

The Global Enoxolone Market was valued at USD 1.9 billion in 2023 and is projected to reach USD 3.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2023 to 2031. Enoxolone, a derivative of glycyrrhetinic acid found in licorice root, is widely used in pharmaceutical, nutraceutical, and cosmetic applications due to its potent anti-inflammatory, anti-ulcer, and antiviral properties. The market growth is propelled by increasing demand for natural therapeutic compounds, a rising focus on gastrointestinal health, and the growing popularity of herbal skincare products.

Drivers:

1. Rising Prevalence of Gastrointestinal Disorders:

Enoxolone is commonly used in treating gastric ulcers and reflux-related conditions. With increasing incidence of gastrointestinal issues driven by poor diets and lifestyle stress, the demand for enoxolone-based medications is on the rise globally.

2. Surge in Natural and Plant-Based Pharmaceuticals:

Consumers are shifting towards natural remedies and botanical extracts. Enoxolone, being plant-derived, fits well within this demand, boosting its usage in over-the-counter drugs and supplements.

3. Expanding Cosmetic Applications:

Enoxolone’s anti-inflammatory and soothing effects are driving its adoption in cosmetic and dermatological formulations, particularly in Asia-Pacific and Europe, where demand for herbal and gentle skincare products is accelerating.

Restraints:

1. Regulatory Hurdles and Quality Concerns:

As a bioactive compound derived from licorice, the production of enoxolone is subject to strict regulations. Variability in raw material quality and differences in regulatory standards across countries can hinder smooth market expansion.

2. Potential Side Effects and Overuse:

Despite its benefits, excessive or prolonged use of enoxolone may result in side effects like hypertension or electrolyte imbalance. These health risks may limit its broader use without medical supervision.

Opportunity:

1. Product Innovation and Formulation Advancements:

The market is witnessing the development of controlled-release tablets and novel enoxolone formulations with enhanced bioavailability. These innovations open new avenues in both human and veterinary healthcare applications.

2. Growth in Emerging Markets:

Rising healthcare awareness, increasing disposable incomes, and an expanding pharmaceutical sector in countries such as India, Brazil, and China offer lucrative opportunities for market players.

Market by System Type Insights:

Based on system type, Pharmaceutical Grade Enoxolone dominated the market in 2023 due to its extensive application in anti-ulcer and anti-inflammatory drug formulations. This segment is anticipated to maintain its lead, driven by growing prescription rates and increasing R&D investments in drug development using plant-based active compounds.

Cosmetic Grade Enoxolone, while smaller in size, is expected to grow rapidly due to its rising usage in anti-aging creams, acne treatments, and soothing serums, especially in Asia-Pacific and European markets.

Market by End-use Insights:

By end use, the Pharmaceutical Industry accounted for the largest market share in 2023. The therapeutic efficacy of enoxolone in managing digestive issues, chronic inflammation, and viral infections is driving sustained demand.

The Cosmetic Industry is projected to witness the highest growth during the forecast period. Rising consumer inclination toward organic skincare and herbal actives is boosting enoxolone’s application in this segment.

Market by Regional Insights:

Geographically, Asia-Pacific led the global enoxolone market in 2023, with countries like China, Japan, and South Korea at the forefront due to their rich history in traditional medicine and the widespread use of licorice-based remedies.

Europe also holds a significant share, especially in the pharmaceutical and cosmetic industries. Meanwhile, North America is emerging as a promising market, with increasing acceptance of herbal medicines and a shift towards natural ingredients in cosmetics and nutraceuticals.

Competitive Scenario:

Leading players in the Global Enoxolone Market include:

Shandong Tianli Pharmaceutical Co., Ltd.

Fujie Pharmaceutical Co., Ltd.

Xi’an Sost Biotech Co., Ltd.

AdooQ BioScience

Gnosis by Lesaffre

These companies are focusing on product quality enhancement, supply chain optimization, and strategic alliances to expand their global footprint.

Scope of Work – Global Enoxolone Market

Report Metric Details

Market Size (2023) USD 1.9 billion

Projected Market Size (2031) USD 3.4 billion

CAGR (2023–2031) 7.4%

Market Segments System Type (Pharmaceutical Grade, Cosmetic Grade), End-use (Pharmaceuticals, Cosmetics), Region

Growth Drivers Rising prevalence of gastrointestinal disorders, shift toward natural therapeutics, cosmetic industry expansion

Opportunities Emerging markets growth, product innovation and controlled-release formulations

Key Market Developments:

2023: Shandong Tianli Pharmaceutical expanded its production line for pharmaceutical-grade enoxolone to meet rising demand in the Asia-Pacific region.

2024: Gnosis by Lesaffre announced a new clinical trial to assess the efficacy of enoxolone in managing chronic inflammatory conditions.

2025: Xi’an Sost Biotech launched a novel encapsulated enoxolone product designed for enhanced skin absorption in cosmetic applications.

FAQs:

What is the current market size of the Global Enoxolone Market?

The Global Enoxolone Market was valued at USD 1.9 billion in 2023.

What is the major growth driver of the Global Enoxolone Market?

The rising prevalence of gastrointestinal disorders and growing demand for plant-based therapeutics are key growth drivers.

Which is the largest region during the forecast period in the Global Enoxolone Market?

Asia-Pacific is projected to dominate the market throughout the forecast period.

Which segment accounted for the largest market share in the Global Enoxolone Market?

The Pharmaceutical Industry segment accounted for the largest market share in 2023.

Who are the key market players in the Global Enoxolone Market?

Key players include Shandong Tianli Pharmaceutical, Fujie Pharmaceutical, Xi’an Sost Biotech, AdooQ BioScience, and Gnosis by Lesaffre.

Let me know if you’d like a PDF or presentation format for this report description!